Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Pharmacogenetics and Genomics|December 12, 2018
Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribingYee Ming Lee, Keith Danahey, Randall W Knoebel, et al.NPJ Breast Cancer|March 15, 2022
Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savingsPo-Hung Hsieh, Alec J Kacew, Marie Dreyer, et al.Journal of Pharmacy Practice|June 15, 2023
Implementation of Debriefing Services for Pharmacy Residents in a 24-Hour, In-House Clinical Pharmacy On-Call Program: A Pilot StudyKevin J Mercer, Kaitlyn E Craddock, Sajni V Patel, et al.Leukemia & Lymphoma|March 11, 2017
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemiaNiloufer Khan, Andrew Hantel, Randall W Knoebel, et al.Journal of Pain Research|December 24, 2024
Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment (C-PAIN): A Randomized Trial of Preemptive <i>CYP2D6</i> Genotyping in Cancer Palliative CareYoungwoo Cho, Theodore Karrison, Matthew M Jack, et al.Pharmacogenetics and Genomics|September 27, 2021
Anesthesia providers as stakeholders to adoption of pharmacogenomic information in perioperative careTien M Truong, Jeffrey L Apfelbaum, Emily Schierer, et al.Clinical Pharmacology and Therapeutics|June 28, 2025
Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment OutcomesYoungwoo Cho, Sami Elahi, Matthew M Jack, et al.Anesthesia and Analgesia|February 25, 2022
Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS TrialTien M Truong, Jeffrey L Apfelbaum, Keith Danahey, et al.Journal of Personalized Medicine|December 24, 2021
Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority PatientsLoren Saulsberry, Keith Danahey, Merisa Middlestadt, et al.The New England Journal of Medicine|December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S Welch, Allegra A Petti, Christopher A Miller, et al.Pageof 3